Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Income from Continuing Operations (2018 - 2025)

Dna X (SONM) has disclosed Income from Continuing Operations for 8 consecutive years, with 4753000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Income from Continuing Operations fell 89.21% year-over-year to 4753000.0, compared with a TTM value of 34030000.0 through Sep 2025, down 154.2%, and an annual FY2024 reading of 34294000.0, down 38004.44% over the prior year.
  • Income from Continuing Operations was 4753000.0 for Q3 2025 at Dna X, up from 7475000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 12843000.0 in Q4 2022 and bottomed at 22260000.0 in Q4 2024.
  • Average Income from Continuing Operations over 5 years is 4473789.47, with a median of 4225000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations surged 209.39% in 2022, then plummeted 1545.23% in 2024.
  • Year by year, Income from Continuing Operations stood at 11741000.0 in 2021, then soared by 209.39% to 12843000.0 in 2022, then plummeted by 110.53% to 1353000.0 in 2023, then tumbled by 1545.23% to 22260000.0 in 2024, then surged by 78.65% to 4753000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for SONM at 4753000.0 in Q3 2025, 7475000.0 in Q2 2025, and 458000.0 in Q1 2025.